Missing HLA C group 1 ligand in patients with AML and MDS is associated with reduced risk of relapse and better survival after allogeneic stem cell transplantation with fludarabine and treosulfan reduced toxicity conditioning

Shimoni, A; Vago, L; Bernardi, M; Yerushalmi, R; Peccatori, J; Greco, R; Shem-Tov, N; Lo Russo, A; Danylesko, I; Apel, A; Bonini, C; Stanghellini, MTL; Nagler, A; Ciceri, F

Shimoni, A (reprint author), Chaim Sheba Med Ctr, Dept Bone Marrow Transplantat, Tel Hashomer, Israel.

AMERICAN JOURNAL OF HEMATOLOGY, 2017; 92 (10): 1011